Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:David_Mack
|
| gptkbp:developedBy |
small molecule drugs
|
| gptkbp:focusesOn |
oncology
precision medicine |
| gptkbp:foundedYear |
2013
|
| gptkbp:founder |
gptkb:Arnold_Levine
gptkb:David_Mack Thomas Shenk |
| gptkbp:hasCompany |
true
|
| gptkbp:headquartersLocation |
gptkb:Cranbury,_New_Jersey,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
PMV Pharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
PC14586
|
| gptkbp:specializesIn |
p53 pathway modulation
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
PMVP
|
| gptkbp:website |
https://www.pmvpharma.com/
|
| gptkbp:bfsParent |
gptkb:Boxer_Capital
|
| gptkbp:bfsLayer |
8
|